More on Track and Trace Bill found at RX Trace Website--

InBrief: A Track And Trace Bill Has Made It To The House Floor

May 15th, 2013 | Author: Dirk Rodgers

On a voice vote, the Energy and Commerce Committee of the U.S. House of Representatives has just passed the recently named “H.R. 1919, Safeguarding America’s Pharmaceuticals Act of 2013” on to the full House of Representatives.  One set of “technical” amendments offered by the bill’s authors was passed and four amendments offered by various Democrats were defeated prior to passage of the full bill by the committee.  This action ensures that the bill will be debated on the full House of Representatives floor at some point in the current session.  This marks the first time since 1987 that a pharmaceutical track and trace bill has made it out of a Congressional committee.
The bill that moves to the House floor has Read the rest of this essay »

 Posted in Congress |  Tags: Congress, Legislation, legitimate pharmaceutical supply chain, pedigree laws |  1 Comment »

An Industry Protection Bill Concealed Under The Veil Of Patient Protection

May 13th, 2013 | Author: Dirk Rodgers

There are two pharmaceutical track & trace bills making their way through committees of Congress,one in the U.S. House of Representatives and one in the Senate.  In both houses, these drafts are touted as bills to protect patients from the ill effects of illegitimate drugs in the legitimate supply chain, but, after reviewing the two drafts at length, I have concluded that the House draft is something else entirely.   Rather than focusing on protection of patients, the House draft is primarily intended to protect the industry from the California pedigree law.  “Patient protection” is little more than a veil to provide cover while the debate is kept on grounds more acceptable to the industry.
Here is my justification for such an assertion.  First, Read the rest of this essay